The Endocrinology of Human Pregnancy and Fetal-Placental Neuroendocrine Development

Yen and Jaffe's Reproductive Endocrinology: Seventh Edition

Volumn , Issue , 2013, Pages 243-271

  Mesiano, Sam ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903221205     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-2758-2.00012-3     Document Type: Chapter

References (362)

1. Kammerer U., von Wolff M., Markert U.R. Immunology of human endometrium. Immunobiology 2004, 209:569-574.
2. Dimitriadis E., White C.A., Jones R.L., Salamonsen L.A. Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update 2005, 11:613-630.
3. Singh M., Chaudhry P., Asselin E. Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors. Endocrinol 2011, 210:5-14.
4. Wilcox A.J., Baird D.D., Weinberg C.R. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999, 340:1796-1799.
5. Nikas G. Endometrial receptivity: changes in cell-surface morphology. Semin Reprod Med 2000, 18:229-235.
6. Gipson I.K., Blalock T., Tisdale A., Spurr-Michaud S., Allcorn S., Stavreus-Evers A., Gemzell K. MUC16 is lost from the uterodome (pinopode) surface of the receptive human endometrium: in vitro evidence that MUC16 is a barrier to trophoblast adherence. Biol Reprod 2008, 78:134-142.
7. Kao L.C., Tulac S., Lobo S., Imani B., Yang J.P., Germeyer A., Osteen K., Taylor R.N., Lessey B.A., Giudice L.C. Global gene profiling in human endometrium during the window of implantation. Endocrinology 2002, 143:2119-2138.
8. Giudice L.C. Microarray expression profiling reveals candidate genes for human uterine receptivity. Am J Pharmacogenomics 2004, 4:299-312.
9. Punnonen R., Lukola A. Binding of estrogen and progestin in the human fallopian tube. Fertil Steril 1981, 36:610-614.
10. Katz-Jaffe M.G., Gardner D.K., Schoolcraft W.B. Proteomic analysis of individual human embryos to identify novel biomarkers of development and viability. Fertil Steril 2006, 85:101-107.
11. Katz-Jaffe M.G., Schoolcraft W.B., Gardner D.K. Analysis of protein expression (secretome) by human and mouse preimplantation embryos. Fertil Steril 2006, 86:678-685.
12. Garrido-Gomez T., Dominguez F., Simon C. Proteomics of embryonic implantation. Handb Exp Pharmacol 2010, 67-78.
13. Quinn C.E., Casper R.F. Pinopodes: a questionable role in endometrial receptivity. Hum Reprod Update 2009, 15:229-236.
14. Nikas G., Aghajanova L. Endometrial pinopodes: some more understanding on human implantation?. Reprod Biomed Online 2002, 4(Suppl 3):18-23.
15. Nikas G. Endometrial receptivity: changes in cell-surface morphology. Seminars in Reproductive Medicine 2000, 18:229-235.
16. Nikas G., Psychoyos A. Uterine pinopodes in peri-implantation human endometrium. Clinical relevance. Annals of the New York Academy of Sciences 1997, 816:129-142.
17. Cross J.C., Werb Z., Fisher S.J. Implantation and the placenta: key pieces of the development puzzle. Science 1994, 266:1508-1518.
18. Paria B.C., Reese J., Das S.K., Dey S.K. Deciphering the cross-talk of implantation: advances and challenges. Science 2002, 296:2185-2188.
19. Strowitzki T., Germeyer A., Popovici R., von Wolff M. The human endometrium as a fertility-determining factor. Hum Reprod Update 2006, 12:617-630.
20. Gellersen B., Brosens I.A., Brosens J.J. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Seminars in Reproductive Medicine 2007, 25:445-453.
21. Herington J.L., Bany B.M. Do molecular signals from the conceptus influence endometrium decidualization in rodents?. J Exp Zool B Mol Dev Evol 2009, 312:797-816.
22. King A., Jokhi P.P., Burrows T.D., Gardner L., Sharkey A.M., Loke Y.W. Functions of human decidual NK cells. Am J Reprod Immunol 1996, 35:258-260. (New York, NY: 1989).
23. Rabot M., Tabiasco J., Polgar B., Aguerre-Girr M., Berrebi A., Bensussan A., Strbo N., Rukavina D., Le Bouteiller P. HLA class I/NK cell receptor interaction in early human decidua basalis: possible functional consequences. Chem Immunol Allergy 2005, 89:72-83.
24. Geva E., Ginzinger D.G., Zaloudek C.J., Moore D.H., Byrne A., Jaffe R.B. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 2002, 87:4213-4224.
25. Sharkey A.M., Charnock-Jones D.S., Boocock C.A., Brown K.D., Smith S.K. Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fert 1993, 99:609-615.
26. Jackson D., Volpert O.V., Bouck N., Linzer D.I. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science 1994, 266:1581-1584.
27. Khong T.Y., De Wolf F., Robertson W.B., Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986, 93:1049-1059.
28. Santoni A., Carlino C., Stabile H., Gismondi A. Mechanisms underlying recruitment and accumulation of decidual NK cells in uterus during pregnancy. Am J Reprod Immunol 2008, 59:417-424.
29. Santoni A., Zingoni A., Cerboni C., Gismondi A. Natural killer (NK) cells from killers to regulators: distinct features between peripheral blood and decidual NK cells. Am J Reproduct Immunol 2007, 58:280-288.
30. Tabiasco J., Rabot M., Aguerre-Girr M., El Costa H., Berrebi A., Parant O., Laskarin G., Juretic K., Bensussan A., Rukavina D., Le Bouteiller P. Human decidual NK cells: unique phenotype and functional properties-a review. Placenta 2006, 27(Suppl A):S34-S39.
31. King A., Hiby S.E., Gardner L., Joseph S., Bowen J.M., Verma S., Burrows T.D., Loke Y.W. Recognition of trophoblast HLA class I molecules by decidual NK cell receptors-a review. Placenta 2000, 21(Suppl A):S81-S85.
32. Le-Bouteiller P. HLA-G in the human placenta: expression and potential functions. Biochem Soc Trans 2000, 28:208-212.
33. Liu K.J., Wang C.J., Chang C.J., Hu H.I., Hsu P.J., Wu Y.C., Bai C.H., Sytwu H.K., Yen B.L. Surface expression of HLA-G is involved in mediating immunomodulatory effects of placenta-derived multipotent cells (PDMCs) towards natural killer lymphocytes. Cell Transplant 2011, vol 20. Numbers 11-12, 2011, pp. 1721-1730(10).
34. van Beekhuizen H.J., Joosten I., Lotgering F.K., Bulten J., van Kempen L.C. Natural killer cells and HLA-G expression in the basal decidua of human placenta adhesiva. Placenta 2010, 31:1078-1084.
35. Jerzak M., Bischof P. Apoptosis in the first trimester human placenta: the role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodelling. Euro J Gynecol Reprod Biol 2002, 100:138-142.
36. Newbern D., Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes 2011, 18:409-416.
37. Waddell B.J. The placenta as hypothalamus and pituitary: possible impact on maternal and fetal adrenal function. Reprod Fert Devel 1993, 5:479-497.
38. Stenman U.H., Tiitinen A., Alfthan H., Valmu L. The classification, functions and clinical use of different isoforms of HCG. Hum Reprod Update 2006, 12:769-784.
39. Valmu L., Alfthan H., Hotakainen K., Birken S., Stenman U.H. Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography-electrospray mass spectrometry. Glycobiology 2006, 16:1207-1218.
40. Haig D. Genetic conflicts in human pregnancy. Quart Rev Biol 1993, 68:495-532.
41. Cole L.A. Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol 2010, 8:102.
42. Banerjee P., Fazleabas A.T. Extragonadal actions of chorionic gonadotropin. Rev Endocr Metab Disord 2011, 12:323-332.
43. Jaffe R.B., Lee P.A., Midgley A.R. Serum gonadotropins before, at the inception of, and following human pregnancy. J Clin Endocrinol Metab 1969, 29:1281-1283.
44. Nisula B.C., Ketelslegers J.M. Thyroid-stimulating activity and chorionic gonadotropin. J Clin Invest 1974, 54:494-499.
45. Carayon P., Lefort G., Nisula B. Interaction of human chorionic gonadotropin and human luteinizing hormone with human thyroid membranes. Endocrinology 1980, 106:1907-1916.
46. Seron-Ferre M., Lawrence C.C., Jaffe R.B. Role of hCG in regulation of the fetal zone of the human fetal adrenal gland. J Clin Endocrinol Metab 1978, 46:834-837.
47. Licht P., Fluhr H., Neuwinger J., Wallwiener D., Wildt L. Is human chorionic gonadotropin directly involved in the regulation of human implantation?. Mol Cell Endocrinol 2007, 269:85-92.
48. Quagliarello J., Goldsmith L., Steinetz B., Lustig D.S., Weiss G. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin. J Clin Endocrinol Metab 1980, 51:74-77.
49. Belmonte A., Ticconi C., Dolci S., Giorgi M., Zicari A., Lenzi A., Jannini E.A., Piccione E. Regulation of phosphodiesterase 5 expression and activity in human pregnant and non-pregnant myometrial cells by human chorionic gonadotropin. J Soc Gynecol Investig 2005, 12:570-577.
50. Toth P., Li X., Lei Z.M., Rao C.V. Expression of human chorionic gonadotropin (hCG)/luteinizing hormone receptors and regulation of the cyclooxygenase-1 gene by exogenous hCG in human fetal membranes. J Clin Endocrinol Metab 1996, 81:1283-1288.
51. Slattery M.M., Brennan C., O'Leary M.J., Morrison J.J. Human chorionic gonadotrophin inhibition of pregnant human myometrial contractility. Br J Obstet Gyn 2001, 108:704-708.
52. Kasahara K., Takakura K., Takebayashi K., Kimura F., Nakanishi K., Noda Y. The role of human chorionic gonadotropin on decidualization of endometrial stromal cells in vitro. J Clin Endocrinol Metab 2001, 86:1281-1286.
53. McGregor W.G., Kuhn R.W., Jaffe R.B. Biologically active chorionic gonadotropin: synthesis by the human fetus. Science 1983, 220:306-308.
54. Gibbons J.M., Mitnick M., Chieffo V. In vitro biosynthesis of TSH- and LH-releasing factors by the human placenta. Am J Obstet Gynecol 1975, 121:127-131.
55. Siler-Khodr T.M., Khodr G.S., Valenzuela G. Immunoreactive gonadotropin-releasing hormone level in maternal circulation throughout pregnancy. Am J Obstet Gynecol 1984, 150:376-379.
56. Sasaki K., Norwitz E.R. Gonadotropin-releasing hormone/gonadotropin-releasing hormone receptor signaling in the placenta. Curr Opin Endocrinol Diabetes Obes 2011, 18:401-408.
57. Currie A.J., Fraser H.M., Sharpe R.M. Human placental receptors for luteinizing hormone releasing hormone. Biochem Biophy Res Comm 1981, 99:332-338.
58. Rabinovici J., Goldsmith P.C., Librach C.L., Jaffe R.B. Localization and regulation of the activin-A dimer in human placental cells. J Clin Endocrinol Metab 1992, 75:571-576.
59. Petraglia F., Sawchenko P., Lim A.T., Rivier J., Vale W. Localization, secretion, and action of inhibin in human placenta. Science 1987, 237:187-189.
60. Muttukrishna S., Child T.J., Groome N.P., Ledger W.L. Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy. Hum Reprod (Oxford, England) 1997, 12:1089-1093.
61. Yokoyama Y., Nakamura T., Nakamura R., Irahara M., Aono T., Sugino H. Identification of activins and follistatin proteins in human follicular fluid and placenta. J Clin Endocrinol Metab 1995, 80:915-921.
62. Florio P., Cobellis L., Luisi S., Ciarmela P., Severi F.M., Bocchi C., Petraglia F. Changes in inhibins and activin secretion in healthy and pathological pregnancies. Mol Cell Endocrinol 2001, 180:123-130.
63. De Bonis M., Torricelli M., Severi F.M., Luisi S., De Leo V., Petraglia F. Neuroendocrine aspects of placenta and pregnancy. Gynecol Endocrinol 2012, 28(Suppl 1):22-26.
64. Petraglia F., Vaughan J., Vale W. Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells. Proc Natl Acad Sci USA 1989, 86:5114-5117.
65. Mersol-Barg M.S., Miller K.F., Choi C.M., Lee A.C., Kim M.H. Inhibin suppresses human chorionic gonadotropin secretion in term, but not first trimester, placenta. J Clin Endocrinol Metab 1990, 71:1294-1298.
66. Anthony R.V., Limesand S.W., Fanning M.D., Liang R. Placental lactogen and growth hormone. The endocrinology of pregnancy 1998, 461-490. Humana Press Inc;, Totowa. F.W. Bazer (Ed.).
67. Grumbach M.M., Kaplan S.L., Sciarra J.J., Burr I.M. Chorionic growth hormone-prolactin (CGP): secretion, disposition, biologic activity in man, and postulated function as the "growth hormone" of the 2d half of pregnancy. Ann New York Acad Sci 1968, 148:501-531.
68. Crosignani P.G., Nencioni T., Brambati B. Concentration of chorionic gonadotrophin and chorionic somatomammotrophin in maternal serum, amniotic fluid and cord blood serum at term. J Obstet Gynaecol Br Commonw 1972, 79:122-126.
69. Kaplan S.L., Gurpide E., Sciarra J.J., Grumbach M.M. Metabolic clearance rate and production rate of chorionic growth hormone-prolactin in late pregnancy. J Clin Endocrinol Metab 1968, 28:1450-1460.
70. Hoshina M., Boothby M., Boime I. Cytological localization of chorionic gonadotropin alpha and placental lactogen mRNAs during development of the human placenta. J Cell Biol 1982, 93:190-198.
71. Jeske W., Soszynski P., Rogozinski W., Lukaszewicz E., Latoszewska W., Snochowska H. Plasma GHRH, CRH, ACTH, beta-endorphin, human placental lactogen, GH and cortisol concentrations at the third trimester of pregnancy. Acta Endocrinol 1989, 120:785-789.
72. Kumasaka T., Nishi N., Yaoi Y., Kido Y., Saito M., Okayasu I., Shimizu K., Hatakeyama S., Sawano S., Kokubu K. Demonstration of immunoreactive somatostatin-like substance in villi and decidua in early pregnancy. Am J Obstet Gynecol 1979, 134:39-44.
73. Tyson J.E., Austin K., Farinholt J., Fiedler J. Endocrine-metabolic response to acute starvation in human gestation. Am J Obstet Gynecol 1976, 125:1073-1084.
74. Hochberg Z., Perlman R., Brandes J.M., Benderli A. Insulin regulates placental lactogen and estradiol secretion by cultured human term trophoblast. J Clin Endocrinol Metab 1983, 57:1311-1313.
75. Gillmer M.D., Oakley N.W., Beard R.W., Brooke F.M., Brudenell M., Chard T. Plasma human placental lactogen profiles over 24 hours in normal and diabetic pregnancy. Br J Obstet Gynaecol 1977, 84:197-204.
76. Liebhaber S.A., Urbanek M., Ray J., Tuan R.S., Cooke N.E. Characterization and histologic localization of human growth hormone-variant gene expression in the placenta. J Clin Invest 1989, 83:1985-1991.
77. Frankenne F., Closset J., Gomez F., Scippo M.L., Smal J., Hennen G. The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab 1988, 66:1171-1180.
78. Eriksson L., Frankenne F., Eden S., Hennen G., Von Schoultz B. Growth hormone 24-h serum profiles during pregnancy-lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 1989, 96:949-953.
79. Rygaard K., Revol A., Esquivel-Escobedo D., Beck B.L., Barrera-Saldana H.A. Absence of human placental lactogen and placental growth hormone (HGH-V) during pregnancy: PCR analysis of the deletion. Hum Genet 1998, 102:87-92.
80. Josimovich J.B. Human placental lactogen: further evidence of placental mimicry of pituitary function. Am J Obstet Gynecol 1974, 120:550-552.
81. Lowman H.B., Cunningham B.C., Wells J.A. Mutational analysis and protein engineering of receptor-binding determinants in human placental lactogen. J Biol Chem 1991, 266:10982-10988.
82. Kaplan S. Human chorionic somatomammotropin: secretion, biological effects and physiological significance. The endocrine milieu of pregnancy, puerperium and childhood: Report of the third Ross conference on obstetric research 1974, OH Ross Laboratories: 75, Columbus.
83. Samaan N., Yen S.C., Gonzalez D., Pearson O.H. Metabolic effects of placental lactogen (HPL) in man. J Clin Endocrinol Metab 1968, 28:485-491.
84. Chen C.L., Chang C.C., Krieger D.T., Bardin C.W. Expression and regulation of proopiomelanocortin-like gene in the ovary and placenta: comparison with the testis. Endocrinology 1986, 118:2382-2389.
85. Liotta A.S., Houghten R., Krieger D.T. Identification of a beta-endorphin-like peptide in cultured human placental cells. Nature 1982, 295:593-595.
86. Grigorakis S.I., Anastasiou E., Dai K., Souvatzoglou A., Alevizaki M. Three mRNA transcripts of the proopiomelanocortin gene in human placenta at term. Eur J Endocrinol 2000, 142:533-536.
87. Raffin-Sanson M.L., Massias J.F., Ankotche A., Coste J., de Keyzer Y., Oliver C., Dumont C., Cabrol D., Ferre F., Bertagna X. High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placenta. Clin Endocrinol (Oxf) 1999, 50:85-94.
88. Rees L.H., Burke C.W., Chard T., Evans S.W., Letchworth A.T. Possible placental origin of ACTH in normal human pregnancy. Nature 1975, 254:620-622.
89. Goland R.S., Wardlaw S.L., Stark R.I., Frantz A.G. Human plasma beta-endorphin during pregnancy, labor, and delivery. J Clin Endocrinol Metab 1981, 52:74-78.
90. Wardlaw S.L., Stark R.I., Baxi L., Frantz A.G. Plasma beta-endorphin and beta-lipotropin in the human fetus at delivery: correlation with arterial pH and pO2. J Clin Endocrinol Metab 1979, 49:888-891.
91. Sastry B.V., Barnwell S.L., Tayeb O.S., Janson V.E., Owens L.K. Occurrence of methionine enkephalin in human placental villus. Biochem Pharmacol 1980, 29:475-478.
92. Valette A., Desprat R., Cros J., Pontonnier G., Belisle S., Lemaire S. Immunoreactive dynorphine in maternal blood, umbilical vein and amniotic fluid. Neuropeptides 1986, 7:145-151.
93. Ahmed M.S., Horst M.A. Opioid receptors of human placental villi modulate acetylcholine release. Life Sci 1986, 39:535-540.
94. McLean M., Smith R. Corticotropin-releasing hormone in human pregnancy and parturition. Trends Endocrinol Metab 1999, 10:174-178.
95. Frim D.M., Emanuel R.L., Robinson B.G., Smas C.M., Adler G.K., Majzoub J.A. Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta. J Clin Invest 1988, 82:287-292.
96. Goland R.S., Wardlaw S.L., Stark R.I., Brown L.S.J., Frantz A.G. High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab 1986, 63:1199-1203.
97. McLean M., Bisits A., Davies J., Woods R., Lowry P., Smith R. A placental clock controlling the length of human pregnancy. Nature Med 1995, 1:460-463.
98. Hillhouse E.W., Grammatopoulos D.K. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev 2006, 27:260-286.
99. Perrin M.H., Donaldson C.J., Chen R., Lewis K.A., Vale W.W. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 1993, 133:3058-3061.
100. Chen R., Lewis K.A., Perrin M.H., Vale W.W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 1993, 90:8967-8971.
101. Perrin M., Donaldson C., Chen R., Blount A., Berggren T., Bilezikjian L., Sawchenko P., Vale W. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 1995, 92:2969-2973.
102. Petraglia F., Sutton S., Vale W. Neurotransmitters and peptides modulate the release of immunoreactive corticotropin-releasing factor from cultured human placental cells. Am J Obstet Gynecol 1989, 160:247-251.
103. Ni X., Chan E.C., Fitter J.T., Smith R. Nitric oxide inhibits corticotropin-releasing hormone exocytosis but not synthesis by cultured human trophoblasts. J Clin Endocrinol Metab 1997, 82:4171-4175.
104. Korebrits C., Yu D.H., Ramirez M.M., Marinoni E., Bocking A.D., Challis J.R. Antenatal glucocorticoid administration increases corticotrophin-releasing hormone in maternal plasma. Br J Obstet Gynaecol 1998, 105:556-561.
105. Marinoni E., Korebrits C., Di Iorio R., Cosmi E.V., Challis J.R. Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy. Am J Obstet Gynecol 1998, 178:770-778.
106. Robinson B.G., Emanuel R.L., Frim D.M., Majzoub J.A. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA 1988, 85:5244-5248.
107. King B.R., Smith R., Nicholson R.C. The regulation of human corticotrophin-releasing hormone gene expression in the placenta. Peptides 2001, 22:1941-1947.
108. Smith R., Mesiano S., Chan E.C., Brown S., Jaffe R.B. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 1998, 83:2916-2920.
109. Chakravorty A., Mesiano S., Jaffe R.B. Corticotropin-releasing hormone stimulates P450 17alpha-hydroxylase/17, 20-lyase in human fetal adrenal cells via protein kinase C. J Clin Endocrinol Metab 1999, 84:3732-3738.
110. Ibanez L., Potau N., Marcos M.V., de Zegher F. Corticotropin-releasing hormone as adrenal androgen secretagogue. Pediatr Res 1999, 46:351-353.
111. Petraglia F., Sawchenko P.E., Rivier J., Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987, 328:717-719.
112. Plotsky P.M. Regulation of hypophysiotropic factors mediating ACTH secretion. Ann New York Acad Sci 1987, 512:205-217.
113. Reis F.M., Petraglia F. The placenta as a neuroendocrine organ. Front Horm Res 2001, 27:216-228.
114. Iavazzo C., Baka S., Malamitsi-Puchner A. The role of urocortin in gynecological and obstetrical conditions. Arch Gynecol Obstet 2009, 279:613-619.
115. Petraglia F., Imperatore A., Challis J.R. Neuroendocrine mechanisms in pregnancy and parturition. Endocr Rev 2010, 31:783-816.
116. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995, 378:287-292.
117. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., Hogenesch J.B., Gulyas J., Rivier J., Vale W.W., Sawchenko P.E. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 2001, 98:2843-2848.
118. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., Vaughan J., Reyes T.M., Gulyas J., Fischer W., Bilezikjian L., Rivier J., Sawchenko P.E., Vale W.W. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 2001, 98:7570-7575.
119. Petraglia F., Florio P., Gallo R., Simoncini T., Saviozzi M., DiBlasio A.M., Vaughan J., Vale W. Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrinol Metab 1996, 81:3807-3810.
120. Imperatore A., Florio P., Torres P.B., Torricelli M., Galleri L., Toti P., Occhini R., Picciolini E., Vale W., Petraglia F. Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes. Am J Obstet Gynecol 2006, 195:288-295.
121. Glynn B.P., Wolton A., Rodriguez-Linares B., Phaneuf S., Linton E.A. Urocortin in pregnancy. Am J Obstst Gynceol 1998, 179:533-539.
122. Petraglia F., Florio P., Benedetto C., Marozio L., DiBlasio A.M., Ticconi C., Piccione E., Luisi S., Genazzani A.R., Vale W. Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. J Clin Endocrinol Metab 1999, 84:1420-1423.
123. Leitch I.M., Boura A.L., Botti C., Read M.A., Walters W.A., Smith R. Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J Clin Endocrinol Metab 1998, 83:4510-4513.
124. Clifton V.L., Read M.A., Leitch I.M., Giles W.B., Boura A.L., Robinson P.J., Smith R. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate-mediated pathway. J Clin Endocrinol Metab 1995, 80:2888-2893.
125. Florio P., Calonaci G., Severi F.M., Torricelli M., Bocchi C., Fiore G., Linton E.A., Petraglia F. Reduced maternal plasma urocortin concentrations and impaired uterine artery blood flow at human mid pregnancy. J Soc Gynecol Investig 2005, 12:191-194.
126. Karteris E., Vatish M., Hillhouse E.W., Grammatopoulos D.K. Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides. J Clin Endocrinol Metab 2005, 90:3680-3687.
127. Rademaker M.T., Charles C.J., Espiner E.A., Fisher S., Frampton C.M., Kirkpatrick C.M., Lainchbury J.G., Nicholls M.G., Richards A.M., Vale W.W. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. J Am Coll Cardiol 2002, 40:1495-1505.
128. Fan J.M., Chen X.Q., Jin H., Du J.Z. Gestational hypoxia alone or combined with restraint sensitizes the hypothalamic-pituitary-adrenal axis and induces anxiety-like behavior in adult male rat offspring. Neuroscience 2009, 159:1363-1373.
129. Karteris E., Hillhouse E.W., Grammatopoulos D. Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility. Endocrinology 2004, 145:890-900.
130. Youngblood W.W., Humm J., Lipton M.A., Kizer J.S. Thyrotropin-releasing hormone-like bioactivity in placenta: evidence for the existence of substances other than Pyroglu-His-Pro-NH2 (TRH) capable of stimulating pituitary thyrotropin release. Endocrinology 1980, 106:541-546.
131. Ahima R., Flier J. Leptin. Annu Rev Physiol 2000, 62:413-437.
132. Elmquist J.K. Anatomic basis of leptin action in the hypothalamus. Front Horm Res 2000, 26:21-41.
133. Bluher S., Mantzoros C.S. Leptin in reproduction. Curr Opin Endocrinol Diabetes Obes 2007, 14:458-464.
134. Harris R.B. Leptin-much more than a satiety signal. Annu Rev Nutr 2000, 20:45-75.
135. Senaris R., Garcia-Caballero T., Casabiell X., Gallego R., Castro R., Considine R.V., Dieguez C., Casanueva F.F. Synthesis of leptin in human placenta. Endocrinology 1997, 138:4501-4504.
136. Henson M.C., Castracane V.D. Leptin in pregnancy. Biol Reprod 2000, 63:1219-1228.
137. Akerman F., Lei Z.M., Rao C.V. Human umbilical cord and fetal membranes co-express leptin and its receptor genes. Gynecol Endocrinol 2002, 16:299-306.
138. Hardie L., Trayhurn P., Abramovich D., Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol (Oxf) 1997, 47:101-106.
139. Hauguel-de Mouzon S., Lepercq J., Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol 2006, 194:1537-1545.
140. Highman T.J., Friedman J.E., Huston L.P., Wong W.W., Catalano P.M. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol 1998, 178:1010-1015.
141. Mukherjea R., Castonguay T.W., Douglass L.W., Moser-Veillon P. Elevated leptin concentrations in pregnancy and lactation: possible role as a modulator of substrate utilization. Life Sci 1999, 65:1183-1193.
142. Chardonnens D., Cameo P., Aubert M.L., Pralong F.P., Islami D., Campana A., Gaillard R.C., Bischof P. Modulation of human cytotrophoblastic leptin secretion by interleukin-1alpha and 17beta-oestradiol and its effect on HCG secretion. Mol Hum Reprod 1999, 5:1077-1082.
143. Jansson N., Greenwood S.L., Johansson B.R., Powell T.L., Jansson T. Leptin stimulates the activity of the system A amino acid transporter in human placental villous fragments. J Clin Endocrinol Metab 2003, 88:1205-1211.
144. DiBona G.F. Neuropeptide Y. American Journal of Physiology Regulatory. Integr Com Physiol 2002, 282:R635-R636.
145. Petraglia F., Calza L., Giardino L., Sutton S., Marrama P., Rivier J., Genazzani A.R., Vale W. Identification of immunoreactive neuropeptide-gamma in human placenta: localization, secretion, and binding sites. Endocrinology 1989, 124:2016-2022.
146. Dotsch J., Nusken K.D., Knerr I., Kirschbaum M., Repp R., Rascher W. Leptin and neuropeptide Y gene expression in human placenta: ontogeny and evidence for similarities to hypothalamic regulation. J Clin Endocrinol Metab 1999, 84:2755-2758.
147. Jang M., Mistry A., Swick A., Romsos D. Leptin rapidly inhibits hypothalamic neuropeptide Y secretion and stimulates corticotropin-releasing hormone secretion in adrenalectomized mice. J Nutr 2000, 130:2813-2820.
148. Petraglia F., Coukos G., Battaglia C., Bartolotti A., Volpe A., Nappi C., Segre A., Genazzani A.R. Plasma and amniotic fluid immunoreactive neuropeptide-Y level changes during pregnancy, labor, and at parturition. J Clin Endocrinol Metab 1989, 69:324-328.
149. Robidoux J., Simoneau L., St-Pierre S., Masse A., Lafond J. Characterization of neuropeptide Y-mediated corticotropin-releasing factor synthesis and release from human placental trophoblasts. Endocrinology 2000, 141:2795-2804.
150. Bowen J.M., Chamley L., Keelan J.A., Mitchell M.D. Cytokines of the placenta and extra-placental membranes: roles and regulation during human pregnancy and parturition. Placenta 2002, 23:257-273.
151. Bowen J.M., Chamley L., Mitchell M.D., Keelan J.A. Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta 2002, 23:239-256.
152. Deal C.L., Guyda H.J., Lai W.H., Posner B.I. Ontogeny of growth factor receptors in the human placenta. Pediatric Res 1982, 16:820-826.
153. Constancia M., Hemberger M., Hughes J., Dean W., Ferguson-Smith A., Fundele R., Stewart F., Kelsey G., Fowden A., Sibley C., Reik W. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 2002, 417:945-948.
154. Crossey P.A., Pillai C.C., Miell J.P. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest 2002, 110:411-418.
155. Wu H.K., Squire J.A., Song Q., Weksberg R. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues. Biochem Biophys Res Com 1997, 233:221-226.
156. Tuckey R.C. Progesterone synthesis by the human placenta. Placenta 2005, 26:273-281.
157. Pion R., Jaffe R., Eriksson G., Wiqvist N., Diczfalusy E. Studies on the metabolism of C-21 steroids in the human foeto-placental unit. I. Formation of a beta-unsaturated 3-ketones in midterm placentas perfused in situ with pregnenolone and 17-alpha-hydroxypregnenolone. Acta Endocrinol 1965, 48:234-248.
158. Escobar J.C., Patel S.S., Beshay V.E., Suzuki T., Carr B.R. The human placenta expresses CYP17 and generates androgens de novo. J Clin Endocrinol Metab 2011, 96:1385-1392.
159. Johansson E. Plasma levels of progesterone in pregnancy measured by a rapid competitive protein binding technique. Acta Endocrinol 1979, 61:607.
160. Mesiano S., Chan E.C., Fitter J.T., Kwek K., Yeo G., Smith R. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab 2002, 87:2924-2930.
161. Hardy D.B., Janowski B.A., Corey D.R., Mendelson C.R. Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression. Mol Endocrinol 2006, 20:2724-2733.
162. Siiteri P.K., Febres F., Clemens L.E., Chang R.J., Gondos B., Stites D. Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant?. Ann N Y Acad Sci 1977, 286:384-397.
163. Norman J.E., Bollapragada S., Yuan M., Nelson S.M. Inflammatory pathways in the mechanism of parturition. BMC Pregnancy Childbirth 2007, 7(Suppl 1):S7.
164. Young A., Thomson A.J., Ledingham M., Jordan F., Greer I.A., Norman J.E. Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term. Biol Reprod 2002, 66:445-449.
165. Thomson A.J., Telfer J.F., Young A., Campbell S., Stewart C.J., Cameron I.T., Greer I.A., Norman J.E. Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod 1999, 14:229-236.
166. Hendricks C.H., Brenner W.E., Gabel R.A., Kerenyi T. The effect of progesterone administered intra-amniotically in late human pregnancy 1961, Brook Lodge Symposium, progesterone, Augusta, Michigan, pp 53-64.
167. Pinto R.M., Montuori E., Lerner U., Baleiron H., Glauberman M., Nemirovsky H. Effect of progesterone on the oxytocic action of estradiol-17-beta. Am J Obstet Gynecol 1965, 91:1084-1089.
168. da Fonseca E.B., Bittar R.E., Carvalho M.H., Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003, 188:419-424.
169. Meis P.J., Klebanoff M., Thom E., Dombrowski M.P., Sibai B., Moawad A.H., Spong C.Y., Hauth J.C., Miodovnik M., Varner M.W., Leveno K.J., Caritis S.N., Iams J.D., Wapner R.J., Conway D., O'Sullivan M.J., Carpenter M., Mercer B., Ramin S.M., Thorp J.M., Peaceman A.M. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003, 348:2379-2385.
170. DeFranco E.A., O'Brien J.M., Adair C.D., Lewis D.F., Hall D.R., Fusey S., Soma-Pillay P., Porter K., How H., Schakis R., Eller D., Trivedi Y., Vanburen G., Khandelwal M., Trofatter K., Vidyadhari D., Vijayaraghavan J., Weeks J., Dattel B., Newton E., Chazotte C., Valenzuela G., Calda P., Bsharat M., Creasy G.W. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007, 30:697-705.
171. Fonseca E.B., Celik E., Parra M., Singh M., Nicolaides K.H. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007, 357:462-469.
172. Hassan S.S., Romero R., Vidyadhari D., Fusey S., Baxter J.K., Khandelwal M., Vijayaraghavan J., Trivedi Y., Soma-Pillay P., Sambarey P., Dayal A., Potapov V., O'Brien J., Astakhov V., Yuzko O., Kinzler W., Dattel B., Sehdev H., Mazheika L., Manchulenko D., Gervasi M.T., Sullivan L., Conde-Agudelo A., Phillips J.A., Creasy G.W. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstst Gynecol 2011, 38:18-31.
173. Romero R., Nicolaides K., Conde-Agudelo A., Tabor A., O'Brien J.M., Cetingoz E., Da Fonseca E., Creasy G.W., Klein K., Rode L., Soma-Pillay P., Fusey S., Cam C., Alfirevic Z., Hassan S.S. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstst Gynecol 2007, 206(124):e1-19.
174. O'Brien J.M., Adair C.D., Lewis D.F., Hall D.R., Defranco E.A., Fusey S., Soma-Pillay P., Porter K., How H., Schackis R., Eller D., Trivedi Y., Vanburen G., Khandelwal M., Trofatter K., Vidyadhari D., Vijayaraghavan J., Weeks J., Dattel B., Newton E., Chazotte C., Valenzuela G., Calda P., Bsharat M., Creasy G.W. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007, 30:687-696.
175. Rouse D.J., Caritis S.N., Peaceman A.M., Sciscione A., Thom E.A., Spong C.Y., Varner M., Malone F., Iams J.D., Mercer B.M., Thorp J., Sorokin Y., Carpenter M., Lo J., Ramin S., Harper M., Anderson G. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007, 357:454-461.
176. Thornton J.G. Progesterone and preterm labor-still no definite answers. N Engl J Med 2007, 357:499-501.
177. Siiteri P.K., MacDonald P.C. Placental estrogen biosynthesis during human pregnancy. J Clin Endocrinol Metab 1966, 26:751-761.
178. Frandsen V.A., Stakeman G. The clinical significance of oestriol estimators in late pregnancy. Acta Endocrinol (Copenh) 1963, 44:183.
179. Goebelsmann U., Chen L.C., Saga M., Nakamura R.M., Jaffe R.B. Plasma concentration and protein binding of oestriol and its conjugates in pregnancy. Acta Endocrinol (Copenh) 1973, 74:592-604.
180. Goebelsmann U., Jaffe R.B. Oestriol metabolism in pregnant women. Acta Endocrinol (Copenh) 1971, 66:679-693.
181. Jaffe R.B., Perez-Palacios G., Lamont K.G., Givner M.L. De novo steriod sulfate biosynthesis. J Clin Endocrinol Metab 1968, 28:1671-1674.
182. Osathanondh R., Canick J., Ryan K.J., Tulchinsky D. Placental sulfatase deficiency: a case study. J Clin Endocrinol Metab 1976, 43:208-214.
183. Tabei T., Heinrichs W.L. Diagnosis of placental sulfatase deficiency. Am J Obststr Gynecol 1976, 124:409-414.
184. Bedin M., Alsat E., Tanguy G., Cedard L. Placental sulfatase deficiency: clinical and biochemical study of 16 cases. Eu J Obstetr Gynecol Reprod Biol 1980, 10:21-34.
185. Bedin M., Fournier T., Cabrol D., Breart G., Kottler M.L., Cedard L. Incidence of placental sulfatase deficiency on the mode of termination of pregnancy. Gynecol Obstetr Inv 1987, 24:86-91.
186. Anderson A.B., Laurence K.M., Turnbull A.C. The relationship in anencephaly between the size of the adrenal cortex and the length of gestation. J Obststr Gyneacol (Br Com) 1969, 76:196-199.
187. Cassady G. Anencephaly. A 6 year study of 367 cases. Am J Obstetr Gynecol 1969, 103:1154-1159.
188. Guha-Ray D.K. Obstetric problems in association with anencephaly. A survey of 60 cases. Obstet Gynecol 1975, 46:569-572.
189. Milic A.B., Adamsons K. The relationship between anencephaly and prolonged pregnancy. J Obststr Gyneacol (Br Com) 1969, 76:102-111.
190. Shozu M., Akasofu K., Harada T., Kubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab 1991, 72:560-566.
191. Harada N., Ogawa H., Shozu M., Yamada K., Suhara K., Nishida E., Takagi Y. Biochemical and molecular genetic analyses on placental aromatase (P-450AROM) deficiency. J Biol Chem 1992, 267:4781-4785.
192. Resnik R., Killam A.P., Battaglia F.C., Makowski E.L., Meschia G. The stimulation of uterine blood flow by various estrogens. Endocrinology 1974, 94:1192-1196.
193. Yang K. Placental 11ß hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids. Rev Reprod 1997, 2:129-132.
194. Mitchell B.F., Seron-Ferre M., Hess D.L., Jaffe R.B. Cortisol production and metabolism in the late gestation rhesus monkey fetus. Endocrinology 1981, 108:916-924.
195. Mitchell B.F., Seron-Ferre M., Jaffe R.B. Cortisol-cortisone interrelationship in the late gestation rhesus monkey fetus in utero. Endocrinology 1982, 111:1837-1842.
196. Seckl R. Glucocorticoids and small babies. Q J Med 1994, 87:259-262.
197. Seckl J.R., Benediktsson R., Lindsay R.S., Brown R.W. Placental 11ß-hydroxysteroid dehydrogenase and the programming of hypertension. J Steroid Biochem Mol Biol 1995, 55:447-455.
198. Burton P.J., Waddell B.J. Dual function of 11ß-hydroxysteroid dehydrogenase in placenta: modulating placenta glucocorticoid passage and local steroid action. Biol Reprod 1999, 60:234-240.
199. Pepe G., Albrecht E. Actions pf placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 1995, 16:608-648.
200. Rasmussen D.D., Liu J.H., Wolf P.L., Yen S.S. Endogenous opioid regulation of gonadotropin-releasing hormone release from the human fetal hypothalamus in vitro. J Clin Endocrinol Metab 1983, 57:881-884.
201. Kaplan S.L., Grumbach M.M., Aubert M.L. The ontogenesis of pituitary hormones and hypothalamic factors in the human fetus: maturation of central nervous system regulation of anterior pituitary function. Recent Prog Horm Res 1976, 32:161-243.
202. Huhtaniemi I.T., Korenbrot C.C., Seron-Ferre M., Foster D.B., Parer J.T., Jaffe R.B. Stimulation of testosterone production in vivo and in vitro in the male rhesus monkey fetus in late gestation. Endocrinology 1977, 100:839-844.
203. Bresson J.L., Clavequin M.C., Fellmann D., Bugnon C. Ontogeny of the neuroglandular system revealed with HPGRF 44 antibodies in human hypothalamus. Neuroendocrinology 1984, 39:68-73.
204. Blumenfeld Z., Jaffe R.B. Hypophysiotropic and neuromodulatory regulation of adrenocorticotropin in the human fetal pituitary gland. J Clin Invest 1986, 78:288-294.
205. Bresson J.L., Clavequin M.C., Fellmann D., Bugnon C. Human corticoliberin hypothalamic neuroglandular system: comparative immunocytochemical study with anti-rat and anti-ovine corticotropin-releasing factor sera in the early stages of development. Brain Res 1987, 429:241-246.
206. Ackland J.F., Ratter S.J., Bourne G.L., Rees L.H. Corticotrophin-releasing factor-like immunoreactivity and bioactivity of human fetal and adult hypothalami. J Endocrinol 1986, 108:171-180.
207. Nobin A., Bjorklund A. Topography of the monoamine neuron systems in the human brain as revealed in fetuses. Acta Physiol Scand Suppl 1973, 388:1-40.
208. McNeilly A.S., Gilmore D., Dobbie G., Chard T. Prolactin releasing activity in the early human foetal hypothalamus. J Endocrinol 1977, 73:533-534.
209. Baker B.L., Jaffe R.B. The genesis of cell types in the adenohypophysis of the human fetus as observed with immunocytochemistry. Am J Anat 1975, 143:137-161.
210. Ishimoto H., Jaffe R.B. Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit. Endocr Rev 2011, 32:317-355.
211. Mesiano S., Jaffe R.B. Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 1997, 18:378-403.
212. Pepe G.J., Albrecht E.D. Regulation of the primate fetal adrenal cortex. Endocr Rev 1990, 11:151-176.
213. Sucheston M., Cannon M. Development of zonular patterns in the human adrenal gland. J Morphol 1968, 126:477-491.
214. Spencer S.J., Mesiano S., Lee J.Y., Jaffe R.B. Proliferation and apoptosis in the human adrenal cortex during the fetal and perinatal periods: implications for growth and remodeling. J Clin Endocrinol Metab 1999, 84:1110-1115.
215. Mesiano S., Coulter C.L., Jaffe R.B. Localization of cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17 alpha-hydroxylase/17, 20-lyase, and 3 beta-hydroxysteroid dehydrogenase isomerase steroidogenic enzymes in human and rhesus monkey fetal adrenal glands: reappraisal of functional zonation. J Clin Endocrinol Metab 1993, 77:1184-1189.
216. Mesiano S., Mellon S.H., Gospodarowicz D., Di Blasio A.M., Jaffe R.B. Basic fibroblast growth factor expression is regulated by ACTH in the human fetal adrenal: a model for adrenal growth regulation. Proc Natl Acad Sci USA 1991, 88:5428-5431.
217. Mesiano S., Jaffe R.B. Role of growth factors in the developmental regulation of the human fetal adrenal cortex. Steroids 1997, 62:62-72.
218. Miller W.L. The syndrome of 17,20 lyase deficiency. J Clin Endocrinol Metab 2012, 97:59-67.
219. 14C]-progesterone by the previable human fetus. J Steroid Biochem 1977, 8:499-504.
220. Doody K.M., Carr B.R., Rainey W.E., Byrd W., Murry B.A., Strickler R.C., Thomas J.L., Mason J.I. 3ß-hydroxysteroid dehydrogenase/isomerase in the fetal zone and neocortex of the human fetal adrenal gland. Endocrinology 1990, 126:2487-2492.
221. Coulter C.L., Goldsmith P.C., Mesiano S., Voytek C.C., Martin M.C., Mason J.I., Jaffe R.B. Functional maturation of the primate fetal adrenal in vivo. II. Ontogeny of corticosteroid synthesis is dependent upon specific zonal expression of 3 beta-hydroxysteroid dehydrogenase/isomerase. Endocrinology 1996, 137:4953-4959.
222. Bayard F., Ances I., Tapper A., Weldon V., Kowarski A., Migeon C. Transplacental passage and fetal secretion of aldosterone. J Clin Invest 1970, 49:1389-1393.
223. Nelson H., Kuhn R., Deyman M., Jaffe R. Human fetal adrenal definitive and fetal zone metabolism of pregnenolone and corticosterone: alternate biosynthetic pathways and absence of detectable aldosterene synthesis. J Clin Endocrinol Metab 1990, 70:693-698.
224. Serón-Ferré M., Biglieri E.G., Jaffe R.B. Regulation of mineralocorticoid secretion by the superfused fetal monkey adrenal gland: lack of stimulation of aldosterone by ACTH. J Devel Physiol 1990, 13:33-36.
225. 2 receptor is present in the human fetal adrenal gland throughout the second trimester of gestation. J Clin Endocrinol Metab 1996, 81:3914-3922.
226. Baker T.G., Scrimgeour J.B. Development of the gonad in normal and anencephalic human fetuses. J Reprod Fert 1980, 60:193-199.
227. Gulyas B.J., Hodgen G.D., Tullner W.W., Ross G.T. Effects of fetal or maternal hypophysectomy on endocrine organs and body weight in infant rhesus monkeys (Macaca mulatta): with particular emphasis on oogenesis. Biol Reprod 1977, 16:216-227.
228. Serra G.B., Perez-Palacios G., Jaffe R.B. De novo testosterone biosynthesis in the human fetal testis. J Clin Endocrinol Metab 1970, 30:128-130.
229. Huhtaniemi I.T., Koritnik D.R., Korenbrot C.C., Mennin S., Foster D.B., Jaffe R.B. Stimulation of pituitary-testicular function with gonadotropin-releasing hormone in fetal and infant monkeys. Endocrinology 1979, 105:109-114.
230. Carr B.R., Parker C.R., Ohashi M., MacDonald P.C., Simpson E.R. Regulation of human fetal testicular secretion of testosterone: low-density lipoprotein-cholesterol and cholesterol synthesized de novo as steroid precursor. Am J Obstet Gynecol 1983, 146:241-247.
231. Tapanainen J., Voutilainen R., Jaffe R.B. Low aromatase activity and gene expression in human fetal testes. J Steroid Biochem 1989, 33:7-11.
232. George F.W., Wilson J.D. Conversion of androgen to estrogen by the human fetal ovary. J Clin Endocrinol Metab 1978, 47:550-555.
233. Rabinovici J., Jaffe R.B. Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads. Endocr Rev 1990, 11:532-557.
234. Fisher D.A., Klein A.H. Thyroid development and disorders of thyroid function in the newborn. N Engl J Med 1981, 304:702-712.
235. Melmed S., Harada A., Murata Y., Socol M., Reed A., Carlson H.E., Azukizawa M., Martin C., Jorgensen E., Hershman J.M. Fetal response to thyrotropin-releasing hormone after thyroid hormone administration to the rhesus monkey: lack of pituitary suppression. Endocrinology 1979, 105:334-341.
236. Jacobsen B.B., Andersen H., Dige-Petersen H., Hummer L. Thyrotropin response to thyrotropin-releasing hormone in fullterm, euthyroid and hypothyroid newborns. Acta Paediatr Scand 1976, 65:433-438.
237. Fisher D.A., Dussault J.H., Sack J., Chopra I.J. Ontogenesis of hypothalamic-pituitary-thyroid function and metabolism in man, sheep, and rat. Recent Prog Horm Res 1976, 33:59-116.
238. Osathanondh R., Chopra I.J., Tulchinsky D. Effects of dexamethasone on fetal and maternal thyroxine, triiodothyronine, reverse triiodothyronine, and thyrotropin levels. J Clin Endocrinol Metab 1978, 47:1236-1239.
239. Isaac R.M., Hayek A., Standefer J.C., Eaton R.P. Reverse tri-iodothyronine to tri-iodothyronine ratio and gestational age. J Pediatr 1979, 94:477-479.
240. Chopra I.J., Sack J., Fisher D.A. Circulating 3,5,3'-triiodothyronine (reverse T3) in the human newborn. J Clin Invest 1975, 55:1137-1141.
241. Abuid J., Stinson D.A., Larsen P.R. Serum triiodothyronine and thyroxine in the neonate and the acute increases in these hormones following delivery. J Clin Invest 1973, 52:1195-1199.
242. DeGroot L.J., Robertson M., Rue P.A. Triiodothyronine receptors during maturation. Endocrinology 1977, 100:1511-1515.
243. Schwartz H.L., Oppenheimer J.H. Ontogenesis of 3,5,3'-triiodothyronine receptors in neonatal rat brain: dissociation between receptor concentration and stimulation of oxygen consumption by 3,5,3'-triiodothyronine. Endocrinology 1978, 103:943-948.
244. Walker P., Weichsel M.E., Fisher D.A., Guo S.M. Thyroxine increases nerve growth factor concentration in adult mouse brain. Science 1979, 204:427-429.
245. Mulchahey J.J., DiBlasio A.M., Martin M.C., Blumenfeld Z., Jaffe R.B. Hormone production and peptide regulation of the human fetal pituitary gland. Endocr Rev 1987, 8:406-425.
246. Goodyer C.G., Sellen J.M., Fuks M., Branchaud C.L., Lefebvre Y. Regulation of growth hormone secretion from human fetal pituitaries: interactions between growth hormone releasing factor and somatostatin. Reprod Nutr Dev 1987, 27:461-470.
247. Grumbach M.M., Gluckman P.D. The human fetal hypothalamus and pituitary gland: the maturation of neuroendocrine mechanisms controlling secretion of fetal pituitary growth hormone, prolactin, gonadotropins, adrenaocorticotropin-related peptides and thyrotropin 1994, 193-261. WB Saunders, Philadelphia, Maternal-fetal endocrinology. D. Tulchinsky, A.B. Little (Eds.).
248. Barker D.J. The developmental origins of adult disease. J Am Coll Nutr 2004, 23:588S-595S.
249. McMillen I.C., Robinson J.S. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005, 85:571-633.
250. Bloomfield F.H., Oliver M.H., Hawkins P., Holloway A.C., Campbell M., Gluckman P.D., Harding J.E., Challis J.R. Periconceptional undernutrition in sheep accelerates maturation of the fetal hypothalamic-pituitary-adrenal axis in late gestation. Endocrinology 2004, 145:4278-4285.
251. Rehman K.S., Sirianni R., Parker C.R., Rainey W.E., Carr B.R. The regulation of adrenocorticotrophic hormone receptor by corticotropin-releasing hormone in human fetal adrenal definitive/transitional zone cells. Reprod Sci 2007, 14:578-587.
252. Gabory A., Attig L., Junien C. Developmental programming and epigenetics. Am J Clin Nutr 2011, 94:S1943-S1952.
253. Martin-Subero J.I. How epigenomics brings phenotype into being. Pediatr Endocrinol Rev 2011, 9(Suppl 1):506-510.
254. Bernstein B.E., Meissner A., Lander E.S. The mammalian epigenome. Cell 2007, 128:669-681.
255. Reik W., Dean W., Walter J. Epigenetic reprogramming in mammalian development. Science 2001, 293:1089-1093.
256. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007, 8:253-262.
257. Cutfield W.S., Hofman P.L., Mitchell M., Morison I.M. Could epigenetics play a role in the developmental origins of health and disease?. Pediatr Res 2007, 61:68R-75R.
258. Mathers J.C., McKay J.A. Epigenetics-potential contribution to fetal programming. Adv Exp Med Biol 2009, 646:119-123.
259. Gabory A., Attig L., Junien C. Epigenetic mechanisms involved in developmental nutritional programming. World J Diabetes 2011, 2:164-175.
260. Liggins G.C. The role of cortisol in preparing the fetus for birth. Reprod Fert Dev 1994, 6:141-150.
261. Liggins G.C. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 1969, 45:515-523.
262. Price H.V., Cone B.R., Keogh M. Length of gestation in congenital adrenal hyperplasia. J Obstet Gynecol Br Comm 1971, 78:430-434.
263. Patrick J.E., Challis J.R.G., Natale R., Richardson B. Circadian rhythms in maternal plasma cortisol, estrone, estradiol and estriol at 34 to 35 weeks' gestation. Am J Obstet Gynecol 1979, 135:791-798.
264. Casey M.L., Macdonald P.C. Endocrine changes of pregnancy. Williams Textbook of Endocrinology 1998, 1259-1271. W.B. Saunders Co;, Philadelphia. J.D. Wilson, D.W. Foster, H.M. Kronenberg, P.R. Larsen (Eds.).
265. Challis J.R.G., Lye S.J. Parturition. The physiology of reproduction 1994, 985-1031. Raven Press, New York. E. Knobil, J.D. Neil (Eds.).
266. Young I.R., Renfree M.B., Mesiano S., Shaw G., Jenkin G., Smith R. The comparative physiology of parturition in mammals: hormones and parturition in mammals. Hormones and reproduction in vertebrates 2010, Academic Press, London. D. Norris, K. Lopez (Eds.).
267. Liggins G.C., Fairclough R.J., Grieves S.A., Kendall J.Z., Knox B.S. The mechanism of initiation of parturition in the ewe. Recent Prog Horm Res 1973, 29:111-159.
268. Flint A.P.P., Anderson A.B.M., Steele P.A., Turnbull A.C. The mechanism by which foetal cortisol controls the onset of parturition in the sheep. Biochem Soc Trans 1975, 3:1189-1194.
269. Honnebier W.J., Swaab D.F. The influence of anencephaly upon intrauterine growth of fetus and placenta and upon gestation length. J Obstet Gynaecol Br Comm 1973, 80:577-588.
270. Walsh S., Kittinger G., Novy M. Maternal peripheral concentrations of estradiol, estrone, cortisol, and progesterone during late pregnancy in rhesus monkeys (Macaca mulatta) and after experimental fetal anencephaly and fetal death. Am J Obstet Gynecol 1979, 135:37-42.
271. Neilson J.P. Mifepristone for induction of labour. Cochrane Database Syst Rev 2000, CD002865.
272. McEwan I.J. Nuclear receptors: one big family. Methods Mol Biol 2009, 505:3-18.
273. Hirata S., Shoda T., Kato J., Hoshi K. Isoform/variant mRNAs for sex steroid hormone receptors in humans. Trends Endocrinol Metab 2003, 14:124-129.
274. Giangrande P.H., Kimbrel E.A., Edwards D.P., McDonnell D.P. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol 2000, 20:3102-3115.
275. Mesiano S., Chan E.C., Fitter J.T., Kwek K., Yeo G., Smith R. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab 2002, 87:2924-2930.
276. Merlino A.A., Welsh T.N., Tan H., Yi L.J., Cannon V., Mercer B.M., Mesiano S. Nuclear progesterone receptors in the human pregnancy myometrium: evidence that parturition involves functional progesterone withdrawal mediated by increased expression of progesterone receptor-A. J Clin Endocrinol Metab 2007, 92:1927-1933.
277. Pieber D., Allport V.C., Hills F., Johnson M., Bennett P.R. Interaction between progesterone receptor isoforms in myometrial cells in human labour. Mol Hum Reprod 2001, 7:875-879.
278. Haluska G.J., Wells T.R., Hirst J.J., Brenner R.M., Sadowsky D.W., Novy M.J. Progesterone receptor localization and isoforms in myometrium, decidua, and fetal membranes from rhesus macaques: evidence for functional progesterone withdrawal at parturition. J Soc Gynecol Investig 2002, 9:125-136.
279. Chai S.Y., Smith R., Zakar T., Mitchell C., Madsen G.: Term myometrium is characterized by increased activating epigenetic modifications at the progesterone receptor-A promoter, Mol Hum Reprod. Published online Feb 27, 2012.
280. Condon J.C., Jeyasuria P., Faust J.M., Wilson J.W., Mendelson C.R. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci U S A 2003, 100:9518-9523.
281. Henderson D., Wilson T. Reduced binding of progesterone receptor to its nuclear response element after human labor onset. Am J Obstet Gynecol 2001, 185:579-585.
282. Dong X., Shylnova O., Challis J.R., Lye S.J. Identification and characterization of the protein-associated splicing factor as a negative co-regulator of the progesterone receptor. J Biol Chem 2005, 280:13329-13340.
283. Kalkhoven E., Wissink S., van der Saag P.T., van der Burg B. Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor. J Biol Chem 1996, 271:6217-6224.
284. Gustafsson J.A. An update on estrogen receptors. Seminars Perinatol 2000, 24:66-69.
285. Haluska G.J., West N.B., Novy M.J., Brenner R.M. Uterine estrogen receptors are increased by RU486 in late pregnant rhesus macaques but not after spontaneous labor. J Clin Endocrinol Metab 1990, 70:181-186.
286. Osman I., Young A., Ledingham M.A., Thomson A.J., Jordan F., Greer I.A., Norman J.E. Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod 2003, 9:41-45.
287. Cox S.M., Casey M.L., MacDonald P.C. Accumulation of interleukin-1beta and interleukin-6 in amniotic fluid: a sequela of labour at term and preterm. Hum Reprod Update 1997, 3:517-527.
288. Mittal P., Romero R., Tarca A.L., Gonzalez J., Draghici S., Xu Y., Dong Z., Nhan-Chang C.L., Chaiworapongsa T., Lye S., Kusanovic J.P., Lipovich L., Mazaki-Tovi S., Hassan S.S., Mesiano S., Kim C.J. Characterization of the myometrial transcriptome and biological pathways of spontaneous human labor at term. J Perinat Med 2010, 38:617-643.
289. Trivedi S., Joachim M., McElrath T., Kliman H.J., Allred E.N., Fichorova R.N., Onderdonk A., Heitor F., Chaychi L., Leviton A., Majzoub J.A. Fetal-placental inflammation, but not adrenal activation, is associated with extreme preterm delivery. Am j Obstetr Gynecol 2012, 206(236):e231-e238.
290. Goldenberg R.L., Culhane J.F. Infection as a cause of preterm birth. Clin Perinatol 2003, 30:677-700.
291. Goldenberg R.L., Hauth J.C., Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med 2000, 342:1500-1507.
292. Andrews W.W., Hauth J.C., Goldenberg R.L. Infection and preterm birth. Am J Perinatol 2000, 17:357-365.
293. Boggess K.A. Pathophysiology of preterm birth: emerging concepts of maternal infection. Clin Perinatol 2005, 32:561-569.
294. Gibbs R.S., Romero R., Hillier S.L., Eschenbach D.A., Sweet R.L. A review of premature birth and subclinical infection. Am J Obststr Gynecol 1992, 166:1515-1528.
295. Romero R., Mazor M., Wu Y.K., Sirtori M., Oyarzun E., Mitchell M.D., Hobbins J.C. Infection in the pathogenesis of preterm labor. Seminars Perinatol 1988, 12:262-279.
296. Romero R., Espinoza J., Goncalves L.F., Kusanovic J.P., Friel L., Hassan S. The role of inflammation and infection in preterm birth. Seminars Reprod Med 2007, 25:21-39.
297. Baggia S., Gravett M.G., Witkin S.S., Haluska G.J., Novy M.J. Interleukin-1 beta intra-amniotic infusion induces tumor necrosis factor-alpha, prostaglandin production, and preterm contractions in pregnant rhesus monkeys. J Soc Gynecol Investig 1996, 3:121-126.
298. Gravett M.G., Witkin S.S., Haluska G.J., Edwards J.L., Cook M.J., Novy M.J. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994, 171:1660-1667.
299. Sadowsky D.W., Adams K.M., Gravett M.G., Witkin S.S., Novy M.J. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obststr Gynecol 2006, 195:1578-1589.
300. Romero R., Mazor M., Tartakovsky B. Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol 1991, 165:969-971.
301. Mitchell M.D., Romero R.J., Edwin S.S., Trautman M.S. Prostaglandins and parturition. Reprod Fertil Dev 1995, 7:623-632.
302. Madsen G., Zakar T., Ku C.Y., Sanborn B.M., Smith R., Mesiano S. Prostaglandins differentially modulate progesterone receptor-A and -B expression in human myometrial cells: evidence for prostaglandin-induced functional progesterone withdrawal. J Clin Endocrinol Metab 2004, 89:1010-1013.
303. Jain J.K., Mishell D.R. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy. N Engl J Med 1994, 331:290-293.
304. Robins J., Mann L.I. Midtrimester pregnancy termination by intramuscular injection of a 15-methyl analogue of prostaglandin F2 alpha. Am J Obstet Gynecol 1975, 123:625-631.
305. Tan H., Yi L., Rote N.S., Hurd W.W., Mesiano S. Progesterone receptor-A and -B have opposite effects on proinflammatory gene expression in human myometrial cells: implications for progesterone actions in human pregnancy and parturition. J Clin Endocrinol Metab 2012, 97(5):E719-E730.
306. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
307. Hayden M.S., West A.P., Ghosh S. SnapShot: NF-kappaB signaling pathways. Cell 2006, 127:1286-1287.
308. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev 2004, 18:2195-2224.
309. Bloom S.L., Yost N.P., McIntire D.D., Leveno K.J. Recurrence of preterm birth in singleton and twin pregnancies. Obstet Gynecol 2001, 98:379-385.
310. Elliott J.P. Preterm labor in twins and high-order multiples. Obstetr Gynecol Clin N Am 2005, 32:429-439.
311. Shynlova O., Tsui P., Dorogin A., Langille B.L., Lye S.J. The expression of transforming growth factor beta in pregnant rat myometrium is hormone and stretch dependent. Reproduction 2007, 134:503-511.
312. Shynlova O., Williams S.J., Draper H., White B.G., Macphee D.J., Lye S.J. Uterine stretch regulates temporal and spatial expression of fibronectin protein and its alpha 5 integrin receptor in myometrium of unilaterally pregnant rats. Biol Reprod 2007, 77(5):880-888.
313. Shynlova O.P., Oldenhof A.D., Liu M., Langille L., Lye S.J. Regulation of c-fos expression by static stretch in rat myometrial smooth muscle cells. Am J Obstet Gynecol 2002, 186:1358-1365.
314. Dalrymple A., Mahn K., Poston L., Songu-Mize E., Tribe R.M. Mechanical stretch regulates TRPC expression and calcium entry in human myometrial smooth muscle cells. Mol Hum Reprod 2007, 13(3):171-179.
315. Loudon J.A., Sooranna S.R., Bennett P.R., Johnson M.R. Mechanical stretch of human uterine smooth muscle cells increases IL-8 mRNA expression and peptide synthesis. Mol Hum Reprod 2004, 10:895-899.
316. Mitchell J.A., Shynlova O., Langille B.L., Lye S.J. Mechanical stretch and progesterone differentially regulate activator protein-1 transcription factors in primary rat myometrial smooth muscle cells. Am J Physiol Endocrinol Metab 2004, 287:E439-E445.
317. Oldenhof A.D., Shynlova O.P., Liu M., Langille B.L., Lye S.J. Mitogen-activated protein kinases mediate stretch-induced c-fos mRNA expression in myometrial smooth muscle cells. Am J Physiol Cell Physiol 2002, 283:C1530-C1539.
318. Terzidou V., Sooranna S.R., Kim L.U., Thornton S., Bennett P.R., Johnson M.R. Mechanical stretch up-regulates the human oxytocin receptor in primary human uterine myocytes. J Clin Endocrinol Metab 2005, 90:237-246.
319. Condon J.C., Jeyasuria P., Faust J.M., Mendelson C.R. Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc Natl Acad Sci U S A 2004, 101:4978-4983.
320. Garcia-Verdugo I., Tanfin Z., Dallot E., Leroy M.J., Breuiller-Fouche M. Surfactant protein A signaling pathways in human uterine smooth muscle cells. Biol Reprod 2008, 79:348-355.
321. Sun K., Brockman D., Campos B., Pitzer B., Myatt L. Induction of surfactant protein A expression by cortisol facilitates prostaglandin synthesis in human chorionic trophoblasts. J Clin Endocrinol Metab 2006, 91:4988-4994.
322. Smith R., Wickings E., Bowman M., Belleoud A., Dubreuil G., Davies J., Madsen G. Corticotropin-releasing hormone in chimpanzee and gorilla pregnancies. J Clin Endocrinol Metab 1999, 84:2820-2825.
323. Grammatopoulos D., Dai Y., Chen J., Karteris E., Papadopoulou N., Easton A.J., Hillhouse E.W. Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria. J Clin Endocrinol Metab 1998, 83:2539-2544.
324. Grammatopoulos D., Hillhouse E.W. Solubilization and biochemical characterization of the human myometrial corticotrophin-releasing hormone receptor. Mol Cell Endocrinol 1998, 138:185-198.
325. Grammatopoulos D.K. The role of CRH receptors and their agonists in myometrial contractility and quiescence during pregnancy and labour. Front Biosci 2007, 12:561-571.
326. Jin D., He P., You X., Zhu X., Dai L., He Q., Liu C., Hui N., Sha J., Ni X. Expression of corticotropin-releasing hormone receptor type 1 and type 2 in human pregnant myometrium. Reprod Sci 2007, 14:568-577.
327. Jones S.A., Challis J.R. Effects of corticotropin-releasing hormone and adrenocorticotropin on prostaglandin output by human placenta and fetal membranes. Gynecol Obststr Invest 1990, 29:165-168.
328. Jones S.A., Challis J.R. Local stimulation of prostaglandin production by corticotropin-releasing hormone in human fetal membranes and placenta. Biochem Biophys Res Comm 1989, 159:192-199.
329. Quartero H.W., Noort W.A., Fry C.H., Keirse M.J. Role of prostaglandins and leukotrienes in the synergistic effect of oxytocin and corticotropin-releasing hormone (CRH) on the contraction force in human gestational myometrium. Prostaglandins 1991, 42:137-150.
330. Quartero H.W., Fry C.H. Placental corticotrophin releasing factor may modulate human parturition. Placenta 1989, 10:439-443.
331. Benedetto C., Petraglia F., Marozio L., Chiarolini L., Florio P., Genazzani A.R., Massobrio M. Corticotropin-releasing hormone increases prostaglandin F2 alpha activity on human myometrium in vitro. Am J Obstet Gynecol 1994, 171:126-131.
332. Grammatopoulos D., Stirrat G.M., Williams S.A., Hillhouse E.W. The biological activity of the corticotropin-releasing hormone receptor- adenylate cyclase complex in human myometrium is reduced at the end of pregnancy. J Clin Endocrinol Metab 1996, 81:745-751.
333. Grammatopoulos D.K., Randeva H.S., Levine M.A., Katsanou E.S., Hillhouse E.W. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins. Mol Endocrinol 2000, 14:2076-2091.
334. Gao L., Lu C., Xu C., Tao Y., Cong B., Ni X. Differential regulation of prostaglandin production mediated by corticotropin-releasing hormone receptor type 1 and type 2 in cultured human placental trophoblasts. Endocrinology 2008, 149:2866-2876.
335. Olson D.M., Ammann C. Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour. Front Biosci 2007, 12:1329-1343.
336. Khan A.H., Carson R.J., Nelson S.M. Prostaglandins in labor-a translational approach. Front Biosci 2008, 13:5794-5809.
337. Thiery J. Induction of labor with prostaglandins. Human parturition 1979, 155-164. Martinus Nijhoff, The Hague. M. Keirse, A. Anderson, J. Benebroek-Gravenhorst (Eds.).
338. Embrey M. PGE compounds for induction of labor and abortion. Annals NY Acad Sci 1971, 180:518-523.
339. Collins E., Turner G. Maternal effects of regular salicylate ingestion in pregnancy. Lancet 1975, 2:335-338.
340. Lewis R.B., Schulman J.D. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet 1973, 2:1159-1161.
341. Fetalvero K.M., Zhang P., Shyu M., Young B.T., Hwa J., Young R.C., Martin K.A. Prostacyclin primes pregnant human myometrium for an enhanced contractile response in parturition. J Clin Invest 2008, 118:3966-3979.
342. Slater D., Dennes W., Sawdy R., Allport V., Bennett P. Expression of cyclo-oxygenase types-1 and -2 in human fetal membranes throughout pregnancy. J Mol Endocrinol 1999, 22:125-130.
343. Okazaki T., Casey M.L., Okita J.R., MacDonald P.C., Johnston J.M. Initiation of human parturition. XII. Biosynthesis and metabolism of prostaglandins in human fetal membranes and uterine decidua. Am J Obstet Gynecol 1981, 139:373-381.
344. Grigsby P.L., Sooranna S.R., Adu-Amankwa B., Pitzer B., Brockman D.E., Johnson M.R., Myatt L. Regional expression of prostaglandin E2 and F2alpha receptors in human myometrium, amnion, and choriodecidua with advancing gestation and labor. Biol Reprod 2006, 75:297-305.
345. Negishi M., Sugimoto Y., Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochimica Et Biophysica Acta 1995, 1259:109-119.
346. Kotani M., Tanaka I., Ogawa Y., Usui T., Mori K., Ichikawa A., Narumiya S., Yoshimi T., Nakao K. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions. Mol Pharmacol 1995, 48:869-879.
347. Brodt-Eppley J., Myatt L. Prostaglandin receptors in lower segment myometrium during gestation and labor. Obstet Gynecol 1999, 93:89-93.
348. Chibbar R., Miller F.D., Mitchell B.F. Synthesis of oxytocin in amnion, chorion and decidua may influence the timing of human parturition. J Clin Invest 1993, 91:185-192.
349. Fuchs A.R., Romero R., Keefe D., Parra M., Oyarzun E., Behnke E. Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women. Am J Obstet Gynecol 1991, 165:1515-1523.
350. Romero R., Sibai B.M., Sanchez-Ramos L., Valenzuela G.J., Veille J.C., Tabor B., Perry K.G., Varner M., Goodwin T.M., Lane R., Smith J., Shangold G., Creasy G.W. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000, 182:1173-1183.
351. Goodwin T.M., Valenzuela G., Silver H., Hayashi R., Creasy G.W., Lane R. Treatment of preterm labor with the oxytocin antagonist atosiban. Am J Perinatol 1996, 13:143-146.
352. Fuchs A.R., Fuchs F., Husslein P., Soloff M.S., Fernstrom M.J. Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor. Science 1982, 215:1396-1398.
353. Blanks A.M., Shmygol A., Thornton S. Regulation of oxytocin receptors and oxytocin receptor signaling. Seminars Reprod Med 2007, 25:52-59.
354. Achache H., Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 2006, 12:731.
355. Bazer F.W., Spencer T.E., Johnson G.A., Burghardt R.C. Uterine receptivity to implantation of blastocysts in mammals. Front Biosci 2011, 3:745. (Schol Ed).
356. Diedrich K., Fauser B.C., Devroey P., et al. The role of the endometrium and embryo in human implantation. Hum Reprod Update 2007, 13:365.
357. Dimitriadis E., Nie G., Hannan N.J., Paiva P., Salamonsen L.A. Local regulation of implantation at the human fetal-maternal interface. Int J Dev Biol 2010, 54(2-3):313.
358. Gluckman P.D., Hanson M.A., Pinal C. The developmental origins of adult disease. Matern Child Nutr 2005, 1:130.
359. Haig D. Genetic conflicts in human pregnancy. Quart Rev Biol 1993, 68:495.
360. Huppertz B. The anatomy of the normal placenta. J Clin Pathol 2008, 61(12):1296.
361. Mesiano S., Wang Y., Norwitz E.R. Progesterone receptors in the human pregnancy uterus: do they hold the key to birth timing?. Reprod Sci 2011, 18:6-19.
362. Young I.R., Renfree M.B., Mesiano S., Shaw G., Jenkin G., Smith R. The comparative physiology of parturition in mammals: hormones and parturition in mammals. Hormones and reproduction in vertebrates 2010, Academic Press, London. D. Norris, K. Lopez (Eds.).